This report describes a patient case utilizing a nontraditional sedative, continuous infusion ketamine, as an alternative agent for intensive care unit (ICU) sedation. A 27-year-old female presented for neurosurgical management of a coup contrecoup injury, left temporal fracture, epidural hemorrhage (EDH), and temporal contusion leading to sustained mechanical ventilation. The patient experienced profound agitation during mechanical ventilation and developed adverse effects with all traditional sedatives: benzodiazepines, dexmedetomidine, opioids, and propofol. Ketamine was titrated to effect and eliminated the need for other agents. This led to successful ventilator weaning, extubation, and transition of care. Given the unique side effect profile of ketamine, it is imperative that information is disseminated on potential utilization of this agent. More information is needed regarding dosing, monitoring, and long-term effects of utilizing ketamine as a continuous ICU sedative, but given the analgesia, anesthesia, and cardiopulmonary stability, future utilization of this medication for this indication seems promising.
HijaziYBodonianCBolonM. Pharmacokinetics and haemodynamics of ketamine in intensive care patients with brain or spinal cord injury. Br J Anaesth. 2003;90(2):155–160.
10.
KolendaHGremmeltARadingS. Ketamine for analgosedative therapy in intensive care treatment of head-injured patients. Acta Neurochir (Wien). 1996;138(10):1193–1199.
11.
Youssef-AhmedMZSilverPNimkoffL. Continuous infusion of ketamine in mechanically ventilated children with refractory bronchospasm. Intensive Care Med. 1996;22(9):972–976.
12.
ElaminEMHugesLDrewD. Is ketamine the right agent for mechanically ventilated patients?Chest. 2007;132(4_MeetingAbstracts):574.
13.
MillerACJaminCTElaminE. Continuous intravenous infusion of ketamine for maintenance sedation. Minerva Anestesiol. 2011;77(8):812–820.
14.
UmunnaBPTekwaniKBarounisD. Ketamine for continuous sedation of mechanically ventilated patients. J Emerg Trauma Shock. 2015;8(1):11–15.
15.
JacobiJFraserGLCoursinDB; Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists (ASHP), American College of Chest Physicians. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002;30(1):119–141.
16.
BarrJFraserGLPuntilloK; American College of Critical Care Medicine. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263–306.
17.
RikerRRShehabiYBokeschPM; SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA. 2009;301(5):489–499.
18.
PandharipandePPSandersRDGirardTD; MENDS Investigators. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit Care. 2010;14(2):r38.
19.
ShaferA. Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. Crit Care Med. 1998;26(5):947–956.
20.
BauerTMRitzRHaberthürC. Prolonged sedation due to accumulation of conjugated metabolites of midazolam. Lancet. 1995;346(8968):145–147.
21.
BarrJZomorodiKBertacciniEJ. A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model. Anesthesiology. 2001;95(2):286–298.
22.
SwartELZuideveldKPde JonghJ. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients. Br J Clin Pharmacol. 2004;57(2):135–145.
23.
OldenhofHde JongMSteenhoekA. Clinical pharmacokinetics of midazolam in intensive care patients, a wide interpatient variability?Clin Pharmacol Ther. 1988;43(3):263–269.
24.
GreenSMAndolfattoG. Managing propofol-induced hypoventilation. Ann Emerg Med. 2015;65(1):57–60.
25.
JonesGMDoepkerBAErdmanMJ. Predictors of severe hypotension in neurocritical care patients sedated with propofol. Neurocrit Care. 2014;20(2):270–276.
26.
MinerJRGrayROStephensD. Randomized clinical trial of propofol with and without alfentanil for deep procedural sedation in the emergency department. Acad Emerg Med. 2009;16(9):825–834.
27.
Kane-GillSLLeBlancJMDastaJF; Critical Care Pharmacotherapy Trials Network. A multicenter study of the point prevalence of drug-induced hypotension in the ICU. Crit Care Med. 2014;42(10):2197–2203.
28.
JakobSMRuokonenEGroundsRM; Dexmedetomidine for Long-Term Sedation Investigators. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA. 2012;307(11):1151–1160.
29.
WeinbroumAAHalpernPRudickV. Midazolam versus propofol for long-term sedation in the ICU: a randomized prospective comparison. Intensive Care Med. 1997;23(12):1258–1263.
30.
WahrJAPlunkettJJRamsayJG. Cardiovascular responses during sedation after coronary revascularization. Incidence of myocardial ischemia and hemodynamic episodes with propofol versus midazolam. Institutions of the McSPI Research Group. Anesthesiology. 1996;84(6):1350–1360.
31.
MerzTMRegliBRothenHU. Propofol infusion syndrome: a fatal case at a low infusion rate. Anesth Analg. 2006;103(4):1050.
32.
ChukwuemekaAKoRRalph-EdwardsA. Short-term low-dose propofol anaesthesia associated with severe metabolic acidosis. Anaesth Intensive Care. 2006;34(5):651–655.
33.
RobertsRJBarlettaJFFongJJ. Incidence of propofol-related infusion syndrome in critically ill adults: a prospective, multicenter study. Crit Care. 2009;13(5):r169.
34.
BellevilleJPWardDSBloorBC. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology. 1992;77(6):1125–1133.
35.
PasinLGrecoTFeltraccoP. Dexmedetomidine as a sedative agent in critically ill patients: a meta-analysis of randomized controlled trials. PLoS One. 2013;8(12):e82913.
36.
GerlachATMurphyCVDastaJF. An updated focused review of dexmedetomidine in adults. Ann Pharmacother. 2009;43(12):2064–2074.
37.
GreenSMKraussB. The semantics of ketamine. Ann Emerg Med. 2000;36(5):480–482.
38.
DemirerEMillerACElaminEM. Impact of ketamine on dynamic compliance (DC) & airway resistance (AR) of sedated & mechanically ventilated ICU patients. Eur Respir J. 2009;34:p3521.
39.
CorssenGGutierrezJRevesJG. Ketamine in the anesthetic management of asthmatic patients. Anesth Analg. 1972;51(4):588–596.
40.
NettlesDCHerrinTJMullenJG. Ketamine induction in poor-risk patients. Anesth Analg. 1973;52(1):59–64.
41.
ReesDIHowellML. Ketamine-atracurium by continuous infusion as the sole anesthetic for pulmonary surgery. Anesth Analg. 1986;65(8):860–864.
42.
WilliamsGDPhilipBMChuLF. Ketamine does not increase pulmonary vascular resistance in children with pulmonary hypertension undergoing sevoflurane anesthesia and spontaneous ventilation. Anesth Analg. 2007;105(6):1578–1584, table of contents.
43.
BovillJG. Intravenous anesthesia for the patient with left ventricular dysfunction. Semin Cardiothorac Vasc Anesth. 2006;10(1):43–48.
44.
ChristGMundiglerGMerhautC. Adverse cardiovascular effects of ketamine infusion in patients with catecholamine-dependent heart. Anaesth Intensive Care. 1997;25(3):255–259.
45.
SprungJSchuetzSStewartRW. Effects of ketamine on the contractility of failing and nonfailing human heart muscles in vitro. Anesthesiology. 1998;88(5):1202–1210.
46.
HanouzJ-LPersehayeEZhuL. The inotropic and lusitropic effects of ketamine in isolated human atrial myocardium: the effect of adrenoceptor blockade. Anesth Analg. 2004;99(6):1689–1695, table of contents.
47.
TobiasJDMartinLDWetzelRC. Ketamine by continuous infusion for sedation in the pediatric intensive care unit. Crit Care Med. 1990;18(8):819–821.
48.
SchmittnerMDVajkoczySLHornP. Effects of fentanyl and S(+)-ketamine on cerebral hemodynamics, gastrointestinal motility, and need of vasopressors in patients with intracranial pathologies: a pilot study. J Neurosurg Anesthesiol. 2007;19(4):257–262.
49.
SawhneySAgarwalRP. Combination of low dose ketamine and pentazocine—a clinical experience. Indian J Anaesth. 2003;47(6):439–442.
50.
WhitePFHamJWayWL. Pharmacology of ketamine isomers in surgical patients. Anesthesiology. 1980;52(3):231–239.
BergmanSA. Ketamine: review of its pharmacology and its use in pediatric anesthesia. Anesth Prog. 1999;46(1):10–20.
54.
PerumalDKAdhimoolamMSelevarajN. Midazolam premedication for ketamine-induced emergence phenomenon: a prospective observational study. J Res Pharm Pract. 2015;4(2):89–93.
55.
CaricatoATersaliAPitoniS. Racemic ketamine in adult head injury patients: use in endotracheal suctioning. Crit Care. 2013;17(6):r267.
56.
FilanovskyYMillerPKaoJ. Myth: ketamine should not be used as an induction agent for intubation in patients with head injury. CJEM. 2010;12(2):154–157.
57.
GibbsJM. The effect of intravenous ketamine on cerebrospinal fluid pressure. Br J Anaesth. 1972;44(12):1298–1302.
58.
EvansJRosenMWeeksRD. Ketamine in neurosurgical procedures. Lancet. 1971;1(7688):40–41.
59.
ShaprioHMWyteSRHarrisAB. Ketamine anaesthesia in patients with intracranial pathology. Br J Anaesth. 1972;44(11):1200–1204.
60.
WangXDingXTongY. Ketamine does not increase intracranial pressure compared with opioids: meta-analysis of randomized controlled trials. J Anesth. 2014;28(6):821–827.
61.
ErdenIAPamukAGAkinciSB. Comparison of two ketamine-propofol dosing regimens for sedation during interventional radiology procedures. Minerva Anestesiol. 2010;76(4):260–265.
